Abstract
“Snus” consist of loose ground tobacco in a very small tea bag–like pouch, placed behind the upper gum for up to 30 minutes. With a different curing process and in the absence of combustion, several carcinogens are reduced, if not eliminated. Epidemiological studies in Sweden, where snus were developed and adopted by approximately 20% of males, have found few, if any, increases in oral/head cancers or cardiovascular risks. Although snus are considerably safer than cigarettes from the perspective of an individual smoker, from a broader societal perspective, at least three problems suggest the need for regulatory oversight: (1) Snus could serve as a “gateway” product for adolescents; (2) snus could serve as a temporary bridge/replacement product for smokers in situations in which cigarettes cannot be used, thus dampening their motivation to quit smoking; and (3) studies have found potentially heightened risks of pancreatic cancer, premature birth, dental disease, and oral lesions among users.
Get full access to this article
View all access options for this article.
